Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition. Gale M, Li Y, Cao J, Liu ZZ, et al. Cancer Res 2020;80:524-535.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gale M, Li Y, Cao J, Liu ZZ, et al. Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition. Cancer Res 2020;80:524-535.
PMID: 31690671